BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20530155)

  • 21. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma.
    Penner CR; Folpe AL; Budnick SD
    Mod Pathol; 2002 Jul; 15(7):687-91. PubMed ID: 12118104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Coexpression of Schwann cell marker GFAP and myoepithelial cell marker alpha-SMA in salivary adenoid cystic carcinoma].
    Sun MY; Chen W; Yang LJ; Dong SZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Aug; 41(8):461-3. PubMed ID: 17074178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metallothionein immunostaining in adenoid cystic carcinomas of the salivary glands.
    Alves SM; Cardoso SV; de Fátima Bernardes V; Machado VC; Mesquita RA; Vieira do Carmo MA; Ferreira Aguiar MC
    Oral Oncol; 2007 Mar; 43(3):252-6. PubMed ID: 16857408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
    Ferrazzo KL; Neto MM; dos Santos E; dos Santos Pinto D; de Sousa SO
    J Oral Pathol Med; 2009 Oct; 38(9):701-7. PubMed ID: 19659475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinico-pathological significance of microvessel density and vascular endothelial growth factor expression in adenoid cystic carcinoma of salivary glands].
    Li Z; Tang P; Xu Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 May; 36(3):212-4. PubMed ID: 11812346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of CD43 expression in adenoid cystic carcinomas, polymorphous low-grade adenocarcinomas, and monomorphic adenomas.
    Woo VL; Bhuiya T; Kelsch R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):495-500. PubMed ID: 16997117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12.
    Guan H; Tan J; Zhang F; Gao L; Bai L; Qi D; Dong H; Zhu L; Li X; Liu T
    Histopathology; 2015 May; 66(6):781-90. PubMed ID: 25098606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
    Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
    Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J
    Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Neuropilin-2 in salivary adenoid cystic carcinoma: its implication in tumor progression and angiogenesis.
    Cai Y; Wang R; Zhao YF; Jia J; Sun ZJ; Chen XM
    Pathol Res Pract; 2010 Dec; 206(12):793-9. PubMed ID: 20851535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-6 Integrin, tenascin-C, and MMP-1 expression in salivary gland neoplasms.
    Westernoff TH; Jordan RC; Regezi JA; Ramos DM; Schmidt BL
    Oral Oncol; 2005 Feb; 41(2):170-4. PubMed ID: 15695119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis.
    He JF; Ge MH; Zhu X; Chen C; Tan Z; Li YN; Gu ZY
    Cancer Sci; 2008 Jul; 99(7):1334-40. PubMed ID: 18410404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma.
    Beltran D; Faquin WC; Gallagher G; August M
    J Oral Maxillofac Surg; 2006 Mar; 64(3):415-23. PubMed ID: 16487803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and importance of inhibitor of DNA binding helix-loop-helix protein in salivary adenoid cystic carcinoma.
    Xie W; Li X; Ren G; Guo W
    Br J Oral Maxillofac Surg; 2010 Sep; 48(6):434-7. PubMed ID: 19766362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis.
    Ramer N; Wu H; Sabo E; Ramer Y; Emanuel P; Orta L; Burstein DE
    Cancer; 2010 Jan; 116(1):77-83. PubMed ID: 19877114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Schwann cell differentiation in perineural invasion of adenoid cystic and mucoepidermoid carcinoma of the salivary glands.
    Luo XL; Sun MY; Lu CT; Zhou ZH
    Int J Oral Maxillofac Surg; 2006 Aug; 35(8):733-9. PubMed ID: 16513325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of silencing Id-1 in cell culture of human adenoid cystic carcinoma.
    Liu P; Liu S; Qi H; Li Y; He H; Wei F
    Oral Oncol; 2009 Sep; 45(9):783-8. PubMed ID: 19213597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.
    Holst VA; Marshall CE; Moskaluk CA; Frierson HF
    Mod Pathol; 1999 Oct; 12(10):956-60. PubMed ID: 10530560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
    Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
    Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS; Bento MJ; Palmeira C; Lopes C
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.